Grants per year
Personal profile
Research Interests
Neurovascular Critical Care, Stroke, Stroke of unknown cause, stroke in young people, acute stroke therapy, atrial fibrillation, stem cell therapy for stroke.
Certifications and Licenses
| Vascular Neurology | |
| Neurology |
Training Experience
| 1997 | Internship, Mount Sinai Hospital, Illinois |
| 2000 | Residency, New York Presbyterian Hospital |
| 2001 | Fellowship, Univ. of CA-San Francisco Med. Ctr. |
Education/Academic qualification
Medicine, MD, PhD, Cornell University Medical College
… → 1996
Research interests
- Stroke
Fingerprint
Dive into the research topics where Richard A Bernstein is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
-
Stroke Trials Network - Regional Coordinating Stroke Centers
Prabhakaran, S., Bernstein, R. A. & Roth, E. J.
National Institute of Neurological Disorders and Stroke
8/1/16 → 7/31/18
Project: Research project
-
Protocol #1160-189: Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate (110 mg or 150 mg, oral b.i.d.) Versus Acetylsalicylic Acid (100 mg oral q.d.) in
Bernstein, R. A. & Caprio, F. Z.
Boehringer Ingelheim Pharmaceuticals, Inc.
8/21/15 → 8/21/19
Project: Research project
-
A Phase III, Case Series Clinical Study of the Reversal of the Anticoagulant Effects of Dabigatran by Intravenous Administration of 5.0 g Idarucizumab (BI 655075) in Patients Treated with Dabigatran Etexilate who have Uncontrolled Bleeding or Require Emer
Boehringer Ingelheim Pharmaceuticals, Inc.
4/6/15 → 4/6/18
Project: Research project
-
Study # D5134C00001: A Randomised, Double-Blind, Multinational Study to Prevent Major Vascular Events with Ticagrelor Compared to Aspirin (ASA) in Patients with Acute Ischaemic Stroke or TIA [SOCRATES –Acute Stroke Or Transient IsChaemic Attack TReAted wi
AstraZeneca Pharmaceuticals LP
4/23/14 → 4/22/17
Project: Research project
-
Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry
for the GLORIA-AF Investigators, May 1 2022, In: Clinical Research in Cardiology. 111, 5, p. 560-573 14 p.Research output: Contribution to journal › Article › peer-review
Open Access2 Scopus citations -
Correction to: Comparative effectiveness and safety of non-vitamin K antagonists for atrial fibrillation in clinical practice: GLORIA-AF Registry (Clinical Research in Cardiology, (2022), 111, 5, (560-573), 10.1007/s00392-022-01996-2)
for the GLORIA-AF Investigators, May 2022, In: Clinical Research in Cardiology. 111, 5, p. 593 1 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
The case of a 70-year-old woman presenting with sudden onset apathy and amnesia
Lineback, C. M., Stamm, B., Rosenberg, A. & Bernstein, R. A., Jul 2022, In: Annals of clinical and translational neurology. 9, 7, p. 1100-1101 2 p.Research output: Contribution to journal › Comment/debate › peer-review
Open Access -
Anticoagulant selection in relation to the SAMe-TT2R2 score in patients with atrial fibrillation: The GLORIA-AF registry
the GLORIA-AF Investigators, Mar 1 2021, In: Hellenic Journal of Cardiology. 62, 2, p. 152-157 6 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Effect of long-term continuous cardiac monitoring vs usual care on detection of atrial fibrillation in patients with stroke attributed to large- or small-vessel disease: The stroke-af randomized clinical trial
Bernstein, R. A., Kamel, H., Granger, C. B., Piccini, J. P., Sethi, P. P., Katz, J. M., Vives, C. A., Ziegler, P. D., Franco, N. C. & Schwamm, L. H., Jun 1 2021, In: JAMA - Journal of the American Medical Association. 325, 21, p. 2169-2177 9 p.Research output: Contribution to journal › Article › peer-review
Open Access31 Scopus citations